Le Lézard

Global Electrophoresis Market (2017 to 2028) - Featuring Agilent Technologies, GE Healthcare, Merck Millipore & Bio-Rad Laboratories Among Others - ResearchAndMarkets.com


The "Global Electrophoresis Market Analysis & Trends - Industry Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

The Global Electrophoresis Market is poised to grow strong during the forecast period 2018 to 2028. Some of the prominent trends that the market is witnessing include emerging markets, shift from plant-derived to genome-based drug discovery, and increasing demand for personalized medicine.

This industry report analyses the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2017, 2018 revenue estimations are presented for 2019 and forecasts for 2023 and 2028. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants, and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub-segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

Report Highlights:

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

3.1 Current Trends

3.1.1 Emerging Markets

3.1.2 Shift From Plant Derived to Genome Based Drug Discovery

3.1.3 Increasing Demand for Personalized Medicine

3.1.4 Growth Opportunities/Investment Opportunities

3.2 Drivers

3.3 Constraints

3.4 Industry Attractiveness

3.4.1 Bargaining power of suppliers

3.4.2 Bargaining power of buyers

3.4.3 Threat of substitutes

3.4.4 Threat of new entrants

3.4.5 Competitive rivalry

4 Electrophoresis Market, By Product

4.1 Electrophoresis Reagents

4.1.1 Nucleic Acid Electrophoresis Reagents

4.1.2 Protein Electrophoresis Reagents

4.2 Electrophoresis Software

4.3 Gel Documentation Systems

4.4 Electrophoresis Systems

4.4.1 Capillary Electrophoresis

4.4.1.1 Capillary Zone Electrophoresis

4.4.1.2 Capillary Isotachophoresis

4.4.1.3 Capillary Isoelectric Focusing

4.4.1.4 Micellar Electrokinetic Capillary Chromatography

4.4.1.5 Capillary Electrochromatography

4.4.1.6 Capillary Gel Electrophoresis

4.4.2 Gel Electrophoresis Systems

4.4.2.1 Agarose Gel Electrophoresis

4.4.2.2 Polyacrylamide Gel Electrophoresis

4.4.2.3 Horizontal Gel Electrophoresis Systems

4.4.2.4 Vertical Gel Electrophoresis Systems

4.4.2.4.1 2D Gel Electrophoresis

4.4.2.4.2 1D Gel Electrophoresis

5 Electrophoresis Market, By Application

5.1 Diagnostic

5.2 Research

5.3 Quality Control & Process Validation

6 Electrophoresis Market, By End User

6.1 Pharmaceutical & Biotechnology Companies

6.2 Hospitals & Diagnostic Centers

6.3 Food Safety

6.4 Academic and Research Institutes

6.5 Forensic Laboratories

6.6 Other End Users

7 Electrophoresis Market, By Geography

7.1 North America

7.2 Europe

7.3 Asia Pacific

7.4 Middle East

7.5 Latin America

7.6 Rest of the World (RoW)

8 Key Player Activities

8.1 Acquisitions & Mergers

8.2 Agreements, Partnerships, Collaborations and Joint Ventures

8.3 Product Launch & Expansions

8.4 Other Activities

9 Leading Companies

9.1 Agilent Technologies Inc

9.2 GE Healthcare

9.3 Merck Millipore

9.4 Bio-Rad Laboratories Inc

9.5 Thermo Fisher Scientific Inc

9.6 Shimadzu Corporation

9.7 Danaher Corporation

9.8 Perkinelmer Inc

9.9 Lonza Group Ltd

9.10 Qiagen N.V.

9.11 Harvard Bioscience Inc

9.12 C.B.S. Scientific Company Inc

9.13 Sebia Group

For more information about this report visit https://www.researchandmarkets.com/r/8sffzs



News published on and distributed by: